Scientists at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have re-engineered ...

Regents of the Univ. of California v. Broad Inst., Inc., No. 2022-1594, 2025 WL 1363125 (Fed. Cir. May 12, 2025) - On May 12, ...

Researchers have engineered a compact, high-specificity IscB variant, NovaIscB, for safe, persistent in vivo epigenome ...

The emergence and global spread of antimicrobial resistance (AMR) pose one of the most critical threats to public health in ...

Life is thought to have begun when RNA began replicating itself, and researchers have got close to achieving this in the lab ...

Parkinson's disease is best known for its effects on the central nervous system. In addition, recent scientific advances ...

Bone is a common site for metastasis of solid cancers, but histological and molecular features of bone metastases are not ...

The yeast nuclear endonuclease Rnt1 has a well-characterized role in the maturation of many ncRNA precursors. However, the scope and consequence of its function in mRNA degradation pathways is much ...

Gene delivery systems can target specific brain cells, a breakthrough that could lead to treatments for Parkinson's, ...

A unique feature of HR is that it repairs the damage to the DNA in a highly accurate way. In eukaryotic cells (those with a ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...